Inhibition by 5-fIuorouracil of ERCC1 and γ-glutamylcysteine synthetase messenger RNA expression in a cisplatin-resistant HST-1 human squamous carcinoma cell line

Oncology Research

Volumn 9, Issue 4, 1997, Pages 167-172

  Fujishima, Hiromitsu ^a   Nakano, Shuji ^a   Masumoto, Naoko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Y CGS; 5 fluorouracil; Cisplatin; ERCCI; Mrna expression

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; CISPLATIN; DNA BINDING PROTEIN; DNA TOPOISOMERASE; ENDONUCLEASE; ERCC1 PROTEIN, HUMAN; FLUOROURACIL; GLUTAMATE CYSTEINE LIGASE; MESSENGER RNA; PROTEIN; RNA; THYMIDINE;

ARTICLE; DNA REPAIR; DRUG EFFECT; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DNA REPAIR; DNA TOPOISOMERASES, TYPE I; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; ENDONUCLEASES; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTAMATE-CYSTEINE LIGASE; HUMANS; PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; THYMIDINE;

EID: 0030634810     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Scanion, K. J.; Newman, E. M.; Lu, Y.; Priest, D. G. Biochemical basis for cisplatin and 5-fluorouracil syncrgism in human ovarian carcinoma cells. Proc. Natl. Acad. Sei. USA 83:8923-8925; 1986.
2. Pratesi, G.; Gianni, L.; Manzotti, C.; Zunino, F. Sequence dependence of the antitumor and toxic effects of 5fluorouracil and cis-diamminedichloro-platinum combination on primary colon tumors in mice. Cancer Chemother. Pharmacol. 21:237-240; 1988.
3. Kuroki, M.; Nakano, S.; Mitsugi, K.; Ichinose, I.; Anzai, K.; Nakamura, M.; Nagafuchi, S.; Niho, Y. In vivo comparative therapeutic study of optimal administration of 5-fluorouracil and cisplatin using a newly established HST-1 human squamous-carcinoma cell line. Cancer Chemother. Pharmacol. 29: 273-276; 1992.
4. Esaki, T.; Nakano, S.; Tatsumoto, T.; Kuroki-Migita, M.; Mitsugi, K.; Nakamura, M.; Niho, Y. Inhibition by 5fluorouracil of cis-diammine-dichloroplatinum (Il)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line. Cancer Res. 52:6501-6506; 1992.
5. Esaki, T.; Nakano, S.; Masumoto, N.; Fujishima, H.; Niho, Y. Schedule-dependent reversion of acquired cisplatin resistance by 5-fluorouracil in a newly established cisplatinresistant HST-1 human squamous carcinoma cell line. Int. J. Cancer 65:479-484; 1996.
6. Parker, W. B.; Cheng, Y. C. Metabolism and mechanism of action of 5-fluorouracil. Pharmacol. Ther. 48:381-395; 1990.
7. Westerveld, A.; Hoeijmarkers, J. H. J.; van Duin, M.; de Wit, J.; Odijk, H.; Pastink, A.; Bootsma, D. Molecular cloning and characterization of a human repair gene. Nature 310: 425-429; 1984.
8. Meister, A. Selective modification of glutathione metabolism. Science 220:472-477; 1983.
9. Nakano, S.; Nakayama, M.; Ichinose, I.; Mitsugi, K.; Nagafuchi, S.; Niho, Y. Characterization of a newly established, TA-4-producing squamous carcinoma cell line derived from metastatic tongue carcinoma. Int. J. Cancer 44:301-306; 1989.
10. Maniatis, T.; Fritsch, E. F.; Sambrook, J. Molecular cloning, laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1982.
11. Kotoh, S.; Naito, S.; Yokomizo, A.; Kumazawa, J.; Asakuno, K.; Kohno, K.; Kuwano, M. Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin-resistant bladder cancer cells. Cancer Res. 54:3248-3252; 1994.
12. Kondo, T.; Yoshida, K.; Urata, Y.; Goto, S.; Casa, S.; Taniguchi, N. 7-GlutamyIcysteine synthetase and active transport of glutathione S-conjugate are responsive to heat shock in K562 erythroid cells. J. Biol. Chem. 268:20366-20372; 1993.
13. van Duin, M.; de Wit, J.; Odijk, H.; Westerveld, A.; Yasui, A.; Koken, M. H. M.; Hoeijmakers, J. H. J.; Bootsma, D. Molecular characterization of the human excision repair gene ERCC-1: cDNA cloning and amino acid homology with the yeast DNA repair gene RAD 10. Cell 44:913-923; 1986.
14. Timmer-Bosscha, H.; Mulder, N. H.; de Vries, E. G. E. Modulation of cis-diamminedichloroplatinum(II) resistance: A review. Br. J. Cancer 66:227-238; 1992.
15. Andrews, P. A.; Howell, S. B. Cellular pharmacology of cis-platin: Perspectives on mechanisms of acquired resistance. Cancer Cells 2:35-43; 1990.
16. Masuda, H.; Tanaka, T.; Matsuda, H.; Kusaba, I. Increased removal of DNA-bound platinum in a human ovarian cancer cell line resistant to cis-diamminedichloroplatinum (II). Cancer Res. 50:1863-1866; 1990.
17. Masumoto, N.; Nakano, S.; Esaki, T.; Fujishima, H.; Tatsumoto, T.; Niho, Y. Inhibition of cis-diamminedichloroplatinum(II)-induced DNA interstrand cross-link removal by 7-ethyl-10-hydroxy-camptothecin in HST-1 human squamouscarcinoma cells. Int. J. Cancer 62:70-75; 1995.
18. Ali-Osman, F.; Berger, M. S.; Rajagopal, S.; Spence, A.; Livingston, R. B. Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatininduced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells. Cancer Res. 53:5663-5668; 1993.
19. Westerveld, A.; Hoeijmakers, J. H. J.; van Duin, M.; de Wit, J.; Odijk, H.; Pastink, A.; Bootsma, D. Molecular cloning and characterization of a human repair gene. Nature 310:425429; 1984.
20. Dabholkar, M.; Bostick-Bruton, F.; Weber, C.; Bohr, V. A.; Egwuagu, C.; Reed, E. ERCC-1 and ERCC-2 expression in malignant tissues from ovarian cancer patients. J. Natl. Cancer Inst. 84:1512-1517; 1992.
21. Dabholkar, M.; Vionnet, J.; Bostick-Bruton, F.; Yu, J. J.; Reed, E. Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinumbased chemotherapy. J. Clin. Invest. 94:703-708; 1994.
22. Meijer, C.; Mulder, N. H.; de Vries, E. G. E. The role of detoxifying systems in resistance of tumor cells to cisplatin and adriamycin. Cancer Treat. Rev. 17:389-407; 1990.
23. Godwin, A. K.; Meister, A.; O'dwyer, P. J.; Huang, C. S.; Hamilton, T. C.; Anderson, M. E. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc. Natl. Acad. Sei. USA 89:3070-3074; 1992.
24. Griffith, O. W.; Meister, A. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (s-n-butyl homocysteine sulfoximine). J. Biol. Chem. 254:7558-7560; 1979.
25. Timmer-Bosscha, H.; Mulder, N. H.; de Vries, E. G. E. Modulation of cis-diamminedichloroplatinum(II) resistance: A review. Br. J. Cancer 66:227-238; 1992.
26. Iwata, T.; Watanabe, T.; Kufe, D. W. Effect of 5-fIuorouraciI on globin mRNA synthesis in murine erythroleukemia cells. Biochemistry 25:2703-2707; 1986.
27. Dolnick, B. J.; Pink, J. J. 5-FIuorouracil modulation of dihydrofolate reductase RNA levels in methotrexate-resistant KB cells. J. Biol. Chem. 258:13299-13306; 1983.
28. Hunt, P.; Zsebo, K. M.; Hokom, M. M.; Hornkohl, A.; Birke, N. C.; Del Castillo, J. C.; Martin, F. Evidence that stem cell factor is involved in the rebound thrombocytosis that follows 5-fluorouracil treatment. Blood 15:904-911; 1992.
29. Balaji, K. N.; Nayak, R. Effect of 5-fluorouracil on interleukin-2 expression. Biochem. Biophys. Res. Commun. 187:305309; 1992.
30. Abdalla, E. E.; Blair, G. E.; Jonesm, R. A.; Jones, R. A.; Sue-Ling, H. M.; Johnson, D. Mechanism of synergy of levamisole and fluorouracil: Induction of human leukocyte antigen class I in a colorectal cancer cell line. J. Natl. Cancer Inst. 87:489-496; 1995.
31. Doong, S. L.; Dolnick, B. J. 5-Fluorouracil substitution alters pre-mRNA splicing in vitro. J. Biol. Chem. 263:4467-4473; 1988.
32. Danenberg, P. V.; Shea, L. C. C.; Danenberg, K. Effect of 5-fluorouracil substitution on the self-splicing activity of Tetrahymenaof ribosomal RNA. Cancer Res. 50:1757-1763; 1990.
33. Guthrie, C. Messenger RNA splicing in yeast: Clues to why the spliceosome is a ribonucleoprotein. Science 253:157-163; 1991.
34. Mcpheeters, D. S.; Abelson, J. Mutational analysis of the yeast U2 snRNA suggests a structural similarity to the catalytic core of group I introns. Cell 71:819-831; 1992.
35. Lenz, H. J,.; Manno, D. J.; Danenberg, K. D.; Danenberg, P. V. Incorporation of 5-fluorouracil into U2 and U6 snRNA precursor splicing. J. Biol. Chem. 269:31962-31968; 1994.